The latest closing stock price for Zentalis Pharmaceuticals as of November 20, 2024 is 3.13.
An investor who bought $1,000 worth of Zentalis Pharmaceuticals stock at the IPO in 2020 would have $-865 today, roughly -1 times their original investment - a -33.01% compound annual growth rate over 5 years.
The all-time high Zentalis Pharmaceuticals stock closing price was 84.79 on November 03, 2021.
The Zentalis Pharmaceuticals 52-week high stock price is 18.07, which is 477.3% above the current share price.
The Zentalis Pharmaceuticals 52-week low stock price is 2.66, which is 15% below the current share price.
The average Zentalis Pharmaceuticals stock price for the last 52 weeks is 8.89.
An investor who bought $1,000 worth of Zentalis Pharmaceuticals stock at the IPO in 2020 would have $-865 today, roughly -1 times their original investment - a -33.01% compound annual growth rate over 5 years.
The all-time high Zentalis Pharmaceuticals stock closing price was 84.79 on November 03, 2021.
The Zentalis Pharmaceuticals 52-week high stock price is 18.07, which is 477.3% above the current share price.
The Zentalis Pharmaceuticals 52-week low stock price is 2.66, which is 15% below the current share price.
The average Zentalis Pharmaceuticals stock price for the last 52 weeks is 8.89.